Importantly, a deficiency of MARCH1 promotes the migration and the colony formation of breast cancer cells, which can be blocked by H151 (STING inhibitor), GSK8612 (TBK1 inhibitor), or Torin 1 (mTOR inhibitor). Here, MARCHF1 is linked to breast carcinoma.